Senseonics, Incorporated

Senseonics, Incorporated

Medical Equipment Manufacturing

Germantown, Maryland 11,535 followers

Creators of the first and only long-term implantable CGM

About us

Senseonics, Inc. is a medical device startup company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products that are intended to enable people with diabetes to confidently live their lives with ease. Utilizing breakthrough fluorescence sensing technology, the Senseonics continuous glucose monitoring ("CGM") system is being designed to be the first fully implantable CGM that is highly accurate and stable throughout its long sensor life. The system consists of a very small sensor implanted under the skin, an external transmitter, and a mobile medical application, which allows for discreet, easy access to real-time glucose measurements without the need for a dedicated receiver.

Industry
Medical Equipment Manufacturing
Company size
51-200 employees
Headquarters
Germantown, Maryland
Type
Privately Held
Specialties
diabetes, glucose sensor, continuous glucose monitor, and active implantable medical device

Locations

  • Primary

    20451 Seneca Meadows Pkwy

    Germantown, Maryland 20876, US

    Get directions

Employees at Senseonics, Incorporated

Updates

  • View organization page for Senseonics, Incorporated, graphic

    11,535 followers

    We are delighted to announce our new agreement with Ascensia Diabetes Care “We are extremely excited to be partnering with Ascensia, a leader in the global diabetes space. Ascensia is well known for their high-quality CONTOUR products used by more than 10 million patients world-wide to help manage their diabetes. We believe their global commercial infrastructure and commitment to the Eversense systems will drive market adoption while allowing Senseonics to focus on further development of our implanted technology.” – Tim Goodnow

Similar pages

Browse jobs

Funding

Senseonics, Incorporated 15 total rounds

Last Round

Post IPO debt

US$ 50.0M

See more info on crunchbase